Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Although research using animal models, peripheral and clinical biomarkers, multimodal neuroimaging techniques and (epi)genetic information has advanced our understanding of Attention-Deficit Hyperactivity Disorder (ADHD), the aetiopathology of this neurodevelopmental disorder has still not been elucidated. Moreover, as the primary affected tissue is the brain, access to samples is problematic. Alternative models are therefore required, facilitating cellular and molecular analysis. Recent developments in stem cell research have introduced the possibility to reprogram somatic cells from patients, in this case ADHD, and healthy controls back into their pluripotent state, meaning that they can then be differentiated into any cell or tissue type. The potential to translate patients’ somatic cells into stem cells, and thereafter to use 2- and 3-dimensional (2D and 3D) neuronal cells to model neurodevelopmental disorders and/or test novel drug therapeutics, is discussed in this chapter.

Cite

CITATION STYLE

APA

Yde Ohki, C. M., McNeill, R. V., Nieberler, M., Radtke, F., Kittel-Schneider, S., & Grünblatt, E. (2022). Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD. In Current Topics in Behavioral Neurosciences (Vol. 57, pp. 483–501). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/7854_2022_346

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free